Cite
Motives and Risk Perceptions of Participants in a Phase 1 Trial for Hepatitis C Virus Investigational Therapy in Pregnancy
MLA
Kislovskiy, Yasaswi, et al. “Motives and Risk Perceptions of Participants in a Phase 1 Trial for Hepatitis C Virus Investigational Therapy in Pregnancy.” Research Ethics, vol. 18, no. 2, Apr. 2022, pp. 132–50. EBSCOhost, https://doi.org/10.1177/17470161211066159.
APA
Kislovskiy, Y., Chappell, C., Flaherty, E., Hamm, M. E., de Abril Cameron, F., Krans, E., & Chang, J. C. (2022). Motives and Risk Perceptions of Participants in a Phase 1 Trial for Hepatitis C Virus Investigational Therapy in Pregnancy. Research Ethics, 18(2), 132–150. https://doi.org/10.1177/17470161211066159
Chicago
Kislovskiy, Yasaswi, Catherine Chappell, Emily Flaherty, Megan E. Hamm, Flor de Abril Cameron, Elizabeth Krans, and Judy C. Chang. 2022. “Motives and Risk Perceptions of Participants in a Phase 1 Trial for Hepatitis C Virus Investigational Therapy in Pregnancy.” Research Ethics 18 (2): 132–50. doi:10.1177/17470161211066159.